Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dexamethasone, Melphalan, Actinomycin D, Cytosine Arabinoside (DMAC) Protocol for Dogs with Relapsed Lymphoma

1 Sept 2006

Abstract excerpt

BACKGROUND: In general, treatment of relapsed lymphoma is associated with a lower probability of response and shorter duration of remission. The purpose of this study was to evaluate the efficacy of the combination chemotherapy protocol DMAC (dexamethasone, melphalan, actinomycin D, and cytosine arabinoside) for reinduction of remission in dogs with relapsed lymphoma. HYPOTHESIS: That DMAC would be an effective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Veterinary Oncology Research
Share to Veterinary Orthopedics and Neurology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 17063713
DOI: 10.1111/j.1939-1676.2006.tb00719.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dexamethasone, Melphalan, Actinomycin D, Cytosine Arabinoside (DMAC) Protocol for Dogs with Relapsed LymphomaPMID 17063713Read ↗

Evaluation of Treatment with a Combination of Mycophenolate Mofetil and Prednisolone in Dogs with Meningoencephalomyelitis of Unknown Etiology: a retrospective study of 86 cases (2009-2017)Semantic proximity Read ↗

Clinical and clinicopathological features and outcomes of Miniature Dachshunds with bone marrow disorders.Semantic proximity Read ↗

Quantitative analysis of mRNA for 10 different drug resistance factors in dogs with lymphoma.Semantic proximity Read ↗

Determination of MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma.Semantic proximity Read ↗

Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.Semantic proximity Read ↗

A Multimodal Approach to the Treatment of Some Facial Cancers in DogsSemantic proximity Read ↗

Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogsSemantic proximity Read ↗

Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cellsSemantic proximity Read ↗

B-Cell Lymphoma of the Middle Ear in a Cat that Responded Well to Multidrug ChemotherapySemantic proximity Read ↗

P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.Semantic proximity Read ↗

The Expression of P-Glycoprotein in Canine Lymphoma and Its Association with Multidrug ResistanceSemantic proximity Read ↗

Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinosideSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.